Mayersohn Joel David 4/A
4/A · CITIUS ONCOLOGY, INC. · Filed Dec 22, 2025
Insider Transaction Report
Form 4/AAmended
Mayersohn Joel David
Director
Transactions
- Award
Common Stock
2025-09-19+300,000→ 321,228 total
Footnotes (1)
- [F1]Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.